Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment
View abstract on PubMed
Summary
This summary is machine-generated.The albumin-to-globulin ratio (AGR) and neutrophil-to-lymphocyte ratio (NLR), combined as ANS, show prognostic value in multiple myeloma with renal impairment. High ANS predicts worse survival, aiding risk assessment.
Area Of Science
- Hematology
- Oncology
- Biomarkers
Background
- The albumin-to-globulin ratio (AGR) and neutrophil-to-lymphocyte ratio (NLR) are emerging prognostic indicators in cancer.
- Their combined prognostic value in multiple myeloma (MM) with renal impairment (RI) remains under investigation.
Purpose Of The Study
- To evaluate the prognostic significance of the combined albumin-to-globulin ratio and neutrophil-to-lymphocyte ratio (ANS) in patients with MM and RI.
- To develop a predictive model for overall survival (OS) and progression-free survival (PFS).
Main Methods
- Retrospective analysis of 79 MM patients with RI from 2011-2018.
- Receiver operating curves (ROCs) determined optimal AGR and NLR thresholds.
- Cox regression, Kaplan-Meier analysis, and nomogram construction assessed prognostic values.
Main Results
- Optimal cut-offs: AGR 1.57, NLR 2.27.
- High ANS and high NLR correlated with worse OS and PFS.
- Multivariate analysis confirmed NLR and ANS as independent predictors for OS and PFS; low AGR predicted reduced OS.
- Nomograms accurately predicted OS (c-index: 0.785) and PFS (c-index: 0.786).
Conclusions
- The combined ANS score is a potential prognostic biomarker for MM patients with RI.
- Proposed nomograms can aid in prognostic predictions for this patient group.
Related Concept Videos
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

